Latest Breaking News On - நோய் எதிர்ப்பு சக்தி சிகிச்சை - Page 4 : comparemela.com

(1) COLLEGE STATION, TX / ACCESSWIRE / May 11, 2021 / Enzolytics, Inc. (OTC Markets ENZC or the Company ) today announced it has engaged TEN Associates LLC (the Consultant ) to assist the Company in disseminating and updating meaningful, relevant and factual information about Enzolytics, and its progress in fulfilling its business strategy, to market makers, the brokerage community, individual investors, the media and the public. Since the combination with BioClonetics Immunotherapeutics, Inc. in December of 2020, a little over five months ago, the Company has announced the achievement of and future plans for a series of significant milestones. The management team has concentrated on meeting or beating each of these milestones and furthering its advancement in developing new, patentable therapeutics and completing testing and clinical trials for its ITV-1 compound. Our focus and dedication to our technologies has resulting in our having limited time for providing detailed respo

United statesKostenloser wertpapierhandelTom nelsonCharles cotropiaWhile enzolytics incTexasam universityCompany contactBioclonetics immunotherapeutics incDrug administrationResearch centerEnzolytics incInstitute for preclinicalPress releasesImmune therapeuticInactivated pepsin fractionCollege station